University of Leicester
Browse

Outcome measures in a combined exercise rehabilitation programme for adults with COPD and chronic heart failure: A preliminary stakeholder consensus event.

Download (374.48 kB)
journal contribution
posted on 2019-10-21, 09:05 authored by AV Jones, RA Evans, WD-C Man, CE Bolton, S Breen, PJ Doherty, N Gardiner, L Houchen-Wolloff, JR Hurst, K Jolly, M Maddocks, JK Quint, O Revitt, LB Sherar, RS Taylor, A Watt, J Wingham, J Yorke, SJ Singh
Combined exercise rehabilitation for chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) is potentially attractive. Uncertainty remains as to the baseline profiling assessments and outcome measures that should be collected within a programme. Current evidence surrounding outcome measures in cardiac and pulmonary rehabilitation were presented by experts at a stakeholder consensus event and all stakeholders (n = 18) were asked to (1) rank in order of importance a list of categories, (2) prioritise outcome measures and (3) prioritise baseline patient evaluation measures that should be assessed in a combined COPD and CHF rehabilitation programme. The tasks were completed anonymously and related to clinical rehabilitation programmes and associated research. Health-related quality of life, exercise capacity and symptom evaluation were voted as the most important categories to assess for clinical purposes (median rank: 1, 2 and 3 accordingly) and research purposes (median rank; 1, 3 and 4.5 accordingly) within combined exercise rehabilitation. All stakeholders agreed that profiling symptoms at baseline were 'moderately', 'very' or 'extremely' important to assess for clinical and research purposes in combined rehabilitation. Profiling of frailty was ranked of the same importance for clinical purposes in combined rehabilitation. Stakeholders identified a suite of multidisciplinary measures that may be important to assess in a combined COPD and CHF exercise rehabilitation programme.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: RAE is an NIHR fellow. MM is supported by an NIHR Career Development Fellowship (CDF-2017-009) and by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) South London. CEB is supported by the NIHR Nottingham BRC, Respiratory Theme. WDCM was partly supported by CLAHRC Northwest London at the time of the consensus meeting. SJS is supported by CLAHRC East Midlands.

History

Citation

Chronic Respiratory Disease, 2019, 16

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Infection, Immunity and Inflammation

Version

  • VoR (Version of Record)

Published in

Chronic Respiratory Disease

Publisher

SAGE Publications (UK and US)

eissn

1479-9731

Acceptance date

2019-07-09

Copyright date

2019

Available date

2019-10-21

Publisher version

https://journals.sagepub.com/doi/10.1177/1479973119867952

Notes

Supplemental material for this article is available online.

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC